经颅交流电刺激联合抗抑郁药对抑郁发作的疗效及安全性

doi:10.3969/j.issn.1006-7795.2022.02.014

首都医科大学学报 ›› 2022, Vol. 43 ›› Issue (2): 244-248.doi: 10.3969/j.issn.1006-7795.2022.02.014

• 精神疾病神经调控和康复技术研究 • 上一篇下一篇

经颅交流电刺激联合抗抑郁药对抑郁发作的疗效及安全性

罗炯^1,2, 孙丛丛^1,2, 潘伟刚^1,2, 王丹^1,2, 史晓宁^1,2, 王茜^1,2, 金文青^1,2, 梁立荣³, 杨春林^1,2, 马辛^1,2, 任艳萍^1,2*

1.首都医科大学附属北京安定医院精神科精神疾病诊断与治疗北京市重点实验室&国家精神心理疾病临床医学研究中心,北京 100088;
2.首都医科大学人脑保护高精尖创新中心,北京 100069;
3.首都医科大学附属北京朝阳医院北京市呼吸疾病研究所临床流行病学研究室,北京 100020

收稿日期:2021-11-10 出版日期:2022-04-21 发布日期:2022-04-14
基金资助:
北京市科学技术委员会科技重大专项(D171100007017001)。

Efficacy and safety of transcranial alternating-current stimulation combined with antidepressants in the treatment of depressive episode

Luo Jiong^1,2, Sun Congcong^1,2, Pan Weigang^1,2, Wang Dan^1,2, Shi Xiaoning^1,2, Wang Qian^1,2, Jin Wenqing^1,2, Liang Lirong³, Yang Chunlin^1,2, Ma Xin^1,2, Ren Yanping^1,2*

1. Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing Key Laboratory of Mental Disorders & The National Clinical Research Center for Mental Disorders, Beijing 100088, China;
2. Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069,China;
3. Department of Clinical Epidemiology, Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China

Received:2021-11-10 Online:2022-04-21 Published:2022-04-14
Contact: *E-mail:renyanping@ccmu.edu.cn
Supported by:
Beijing Municipal Science & Technology Commission (D171100007017001).

摘要/Abstract

摘要： 目的探讨经颅交流电刺激(transcranial alternating-current stimulation, tACS) 联合抗抑郁药对抑郁发作的治疗效果及安全性。方法选择抑郁发作患者62例,分为治疗组和对照组,均服用抗抑郁药物,治疗组加用tACS真刺激治疗,对照组加用tACS伪刺激治疗。治疗次数两组均为20次。治疗部位为前额部、双侧乳突部,频率为77.5 Hz,强度为15 mA。采用汉密尔顿抑郁量表-17项(Hamilton Depression Scale-17 Item, HAMD-17),汉密尔顿焦虑量表(Hamilton Anxiety Scale, HAMA)评估患者治疗前后的临床症状,并评估安全性。评估时间点为基线,治疗结束时(4周末),随访时(8周末)。结果采用重复测量方差分析对治疗组和对照组在基线、治疗4周末、随访8周末时HAMD-17和HAMA的评分进行比较,显示两组HAMD-17总分均随治疗及随访时间的延长逐渐降低(P_时间<0.05),治疗组降低幅度大于对照组(P_组间<0.05),且随观察时间的延长治疗的效应增大(P_交互<0.05)。两组HAMA总分均随治疗及随访时间的延长逐渐降低(P_时间<0.05),但两组间差异无统计学意义(P_组间>0.05)。治疗组和对照组第4周末HAMD-17的减分率分别为74.29%±8.40% vs 32.54%±13.30%;第8周末HAMD-17的减分率分别为81.00%±10.68% vs 40.27%±12.92%,差异均有统计学意义(P<0.001)。两组均无严重不良事件发生。结论经颅交流电刺激联合抗抑郁药物治疗抑郁发作能够增强治疗效果,且安全性高,可作为抑郁发作联合治疗的新选择。

关键词: 经颅交流电刺激, 抑郁发作, 疗效, 安全性

Abstract: Objective To investigate the efficacy and safety of transcranial alternating current stimulation (tACS) combined with antidepressants in the treatment of depression. Methods Sixty-two patients with depressive episode were randomly divided into treatment group and control group. Both groups took antidepressants. The patients in the treatment group received real tACS while the patients in the control group were treated with sham tACS. The treatment session was 20 times in both groups. The treatment site was prefrontal and bilateral mastoid, with a frequency of 77.5 Hz and intensity of 15 mA. Hamilton Depression Scale-17 Item (HAMD-17) and Hamilton Anxiety Scale (HAMA) were used to evaluate the clinical symptoms at baseline, the end of treatment (4 weeks), and follow-up (8 weeks). Results The scores of HAMD-17 and HAMA in the treatment and control groups at baseline, 4 weeks of treatment, and 8 weeks of follow-up were compared with repeated measurement analysis of variance. The total score of HAMD-17 in the two groups decreased gradually with the extension of treatment and follow-up time (P _time<0.05). The decrease in the treatment group was greater than that in the control group (P _group<0.05), and the effect of treatment increased with the extension of observation time (P_interaction<0.05). The total score of HAMA in both groups decreased gradually with the extension of treatment and follow-up time (P _time<0.05). However, there was no significant difference between the two groups (P _group>0.05). The score reduction rates of HAMD-17 in the treatment and control groups at the end of the fourth week were74.29%±8.40% vs 32.54%±13.30%, respectively. At the end of the 8th week, the score reduction rates of HAMD-17 were 81.00%±10.68% vs 40.27%±12.92%, respectively. The difference was statistically significant (P<0.001). Conclusion tACS combined with antidepressants is effective and safe in the treatment of depressive episodes. It can be used as a new choice for the combined treatment of depressive episodes.

Key words: transcranial alternating-current stimulation (tACS), depressive episode, efficacy, safety

中图分类号:

R749.4

罗炯, 孙丛丛, 潘伟刚, 王丹, 史晓宁, 王茜, 金文青, 梁立荣, 杨春林, 马辛, 任艳萍. 经颅交流电刺激联合抗抑郁药对抑郁发作的疗效及安全性[J]. 首都医科大学学报, 2022, 43(2): 244-248.

Luo Jiong, Sun Congcong, Pan Weigang, Wang Dan, Shi Xiaoning, Wang Qian, Jin Wenqing, Liang Lirong, Yang Chunlin, Ma Xin, Ren Yanping. Efficacy and safety of transcranial alternating-current stimulation combined with antidepressants in the treatment of depressive episode[J]. Journal of Capital Medical University, 2022, 43(2): 244-248.

参考文献

[1] 马辛, 李淑然, 向应强, 等. 北京市抑郁症的患病率调查[J]. 中华精神科杂志, 2007, 40(2): 100-103.
[2] WHO. Depression and other common mental disorders: global health estimates[R]. Geneva: World Health Organization, 2017: 1-24.
[3] Smith K. Mental health: a world of depression[J]. Nature, 2014, 515(7526): 181.
[4] Fava M. Diagnosis and definition of treatment-resistant depression[J]. Biol Psychiatry, 2003, 53(8): 649-659.
[5] Antal A, Paulus W. Transcranial alternating current stimulation (tACS)[J]. Front Hum Neurosci, 2013, 7: 317.
[6] 王红星, 王坤, 孙志超, 等. 经颅交流电刺激干预从未药物治疗的抑郁症患者的疗效初探[J]. 中华医学杂志, 2020, 100(3): 197-201.
[7] Wilkening A, Kurzeck A, Dechantsreiter E, et al. Transcranial alternating current stimulation for the treatment of major depression during pregnancy[J]. Psychiatry Res, 2019, 279: 399-400.
[8] Haller N, Senner F, Brunoni A R, et al. Gamma transcranial alternating current stimulation improves mood and cognition in patients with major depression[J]. J Psychiatr Res, 2020, 130: 31-34.
[9] American Psychiatric Association. Diagnostic and statistical manual for mental disorders[M]. 5th ed. Washington DC: American Psychiatric Association,2013.
[10] Bergfeld I O, Mantione M, Figee M, et al. Treatment-resistant depression and suicidality[J]. J Affect Disord, 2018, 235: 362-367.
[11] Lebedev V P, Malygin A V, Kovalevski A V, et al. Devices for noninvasive transcranial electrostimulation of the brain endorphinergic system: application for improvement of human psycho-physiological status[J]. Artif Organs, 2002, 26(3): 248-251.
[12] Ai∨rapetov L N, Zai∨chik A M, Trukhmanov M S, et al. Changes in the beta-endorphin levels in the brain and cerebrospinal fluid during transcranial electroanalgesia[J]. Fiziol Zh SSSR Im I M Sechenova, 1985, 71(1): 56-64.
[13] Lande R G, Gragnani C. Efficacy of cranial electric stimulation for the treatment of insomnia: a randomized pilot study[J]. Complement Ther Med, 2013, 21(1): 8-13.
[14] Matsumoto H, Ugawa Y. Adverse events of tDCS and tACS: a review[J]. Clin Neurophysiol Pract, 2017, 2: 19-25.
[15] Fertonani A, Ferrari C, Miniussi C. What do you feel if I apply transcranial electric stimulation? Safety, sensations and secondary induced effects[J]. Clin Neurophysiol, 2015, 126(11): 2181-2188.

经颅交流电刺激联合抗抑郁药对抑郁发作的疗效及安全性

Efficacy and safety of transcranial alternating-current stimulation combined with antidepressants in the treatment of depressive episode

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	任艳萍, 张俊岩, 吴涵, 罗炯, 杨春林, 马辛, 姜玮. 磁惊厥治疗与无抽搐电痉挛治疗抑郁发作的早期疗效及对认知功能的影响[J]. 首都医科大学学报, 2022, 43(2): 239-243.
[2]	李莉, 刘超猛, 任艳萍, 杨春林, 马辛. 改良电休克治疗首发精神分裂症的研究进展[J]. 首都医科大学学报, 2022, 43(2): 249-253.
[3]	何振, 刘娟, 冀明, 李鹏, 张澍田. 内镜下黏膜剥离术治疗累及肛门齿状线直肠病变的临床效果评价[J]. 首都医科大学学报, 2022, 43(1): 38-41.
[4]	朱平, 禹环, 符丽梅, 廖欣, 熊暮珺, 雷阿明, 祝平安, 梁欣荃. 脐血移植治疗难治复发急性白血病的临床分析[J]. 首都医科大学学报, 2021, 42(6): 1041-1045.
[5]	程姣姣, 阮祥燕, 杜娟, 金凤羽, 李扬璐, 谷牧青. 卵巢组织冻存移植安全性的研究进展[J]. 首都医科大学学报, 2021, 42(4): 505-510.
[6]	鄢丹. 临床生物特征谱学:中药质量与临床合理用药评价——鄢丹教授[J]. 首都医科大学学报, 2020, 41(5): 773-777.
[7]	余英, 高峰, 张杰. 反流性食管炎治疗效果与食管下段菌群构成变化的关系研究[J]. 首都医科大学学报, 2020, 41(2): 243-248.
[8]	王希思, 杨维, 黄程, 赵文, 赵倩, 段超, 苏雁, 金眉, 张大伟, 秦红, 王焕民, 马晓莉. 儿童肝母细胞瘤的临床特征和治疗效果评价[J]. 首都医科大学学报, 2019, 40(2): 169-173.
[9]	吕霞丽, 李自慧, 潘丽萍, 贾红彦, 张宗德, 刘洋. 乙酰丙酸－十二烷基硫酸钠对结核分枝杆菌的杀灭作用及其安全性毒理学评价[J]. 首都医科大学学报, 2018, 39(6): 894-899.
[10]	许庆庆, 段甦, 王向东, 张罗. 鼻中隔偏曲矫正对变应性鼻炎患者治疗效果的Meta分析[J]. 首都医科大学学报, 2018, 39(6): 928-932.
[11]	常忠莲, 盛晓滨, 石新兰, 韦薇. 桂枝茯苓汤辨证加味对晚期宫颈癌化学药物治疗患者的增效减毒作用[J]. 首都医科大学学报, 2018, 39(4): 596-601.
[12]	夏鹏飞, 王伟, 邹亮, 马英明. 改良抗血小板药物方案在血小板高反应性未破裂颅内动脉瘤患者介入栓塞中的疗效及安全性[J]. 首都医科大学学报, 2018, 39(1): 143-147.
[13]	刘俊华, 王勇, 王颜颜, 王晓民. 深部脑磁刺激对帕金森病模型大鼠运动症状治疗的安全性评价[J]. 首都医科大学学报, 2017, 38(2): 260-267.
[14]	黄镪, 马青峰, 宋海庆, 武剑. 血糖对急性缺血性卒中静脉溶栓治疗后结局的影响[J]. 首都医科大学学报, 2017, 38(1): 53-58.
[15]	朱虹, 贾竑晓, 阎爱国, 职利花. 齐拉西酮治疗精神分裂症疗效及不良反应的相关因素分析[J]. 首都医科大学学报, 2016, 37(2): 164-167.